Notice2023-01667
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 27, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 18 (Friday, January 27, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 18 (Friday, January 27, 2023)]
[Notices]
[Pages 5358-5359]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-01667]
[[Page 5358]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-23-0004]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``National Disease Surveillance Program II.
Disease Summaries'' to the Office of Management and Budget (OMB) for
review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
September 16, 2022 to obtain comments from the public and affected
agencies. CDC received 2 comments related to the previous notice. This
notice serves to allow an additional 30 days for public and affected
agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
National Disease Surveillance Program II. Disease Summaries (OMB
Control No. 0920-0004)--Reinstatement--National Center for Immunization
and Respiratory Diseases (NCIRD), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
CDC requests a three year approval for the Reinstatement of the
National Disease Surveillance Program II. Disease Summaries information
collection. As with the previous approval, these data are essential for
measuring trends in diseases, evaluating the effectiveness of current
preventive strategies, and determining the need to modify current
preventive measures. Diseases included in this surveillance program are
Influenza Virus, Caliciviruses, Respiratory and Enteric Viruses,
Arthropod-Borne Diseases, Parechoviruses and Enteroviruses. The
proposed Reinstatement with Change includes eight influenza forms,
Suspect Respiratory Virus Patient Form, Middle East Respiratory
Syndrome Coronavirus (MERS) Patient Under Investigation (PUI) Form,
Viral Gastroenteritis Outbreak Submission Form, National Respiratory
and Enteric Virus Surveillance System (NREVSS) Laboratory Assessment,
and National Enterovirus Surveillance Report. These forms have minor
edits with minor burden change from last OMB approval. Additionally,
CDC requests the use of four new forms, Aggregate case counts of
persons exposed to Highly Pathogenic Avian Influenza (HPAI), Pediatric
Hepatitis of Unknown Etiology Medical Record Abstraction Short Form,
Pediatric Hepatitis of Unknown Etiology Medical Record Abstraction Form
(CRF) and Arthropod (Vector)-Borne Diseases (Non-Human Data). The data
from the new forms will enable rapid detection and characterization of
outbreaks of known pathogens, as well as potential newly emerging viral
pathogens.
The frequency of response for each form will depend on the disease
and surveillance need. This represents an increase of 2,657 burden
hours since last approval. This change in burden hours is attributed
primarily to the discontinuation of previously approved forms,
formatting changes to existing forms, and the addition of four new
forms. The total burden estimate for all collection instruments in this
reinstatement request is 27,458. There is no cost to respondents other
than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response (in
respondent hr)
----------------------------------------------------------------------------------------------------------------
Epidemiologist..................... Attachment E--WHO 47 52 10/60
Collaborating center for
Influenza--Influenza Virus
Surveillance.
Epidemiologist..................... Attachment F--U.S. WHO 113 1 10/60
Collaborating Laboratories
Influenza Testing Methods
Assessment.
Epidemiologist..................... Attachment H-US Outpatient 1800 52 10/60
Influenza-like Illness
Surveillance Network
(ILINet) Workfolder 55.20E.
Epidemiologist..................... Attachment J--Influenza- 57 2 30/60
Associated Pediatric
Mortality--Case Report
Form.
Epidemiologist..................... Attachment K--Human 57 2 30/60
Infection with Novel
Influenza A Virus Case
Report Form.
Epidemiologist..................... Attachment M--Human 57 1 90/60
Infection with Novel
Influenza A Virus Severe
Outcomes.
Epidemiologist..................... Attachment P--Novel 57 1 15/60
Influenza A Virus Case
Screening Form.
[[Page 5359]]
Epidemiologist..................... Attachment T--Antiviral 57 3 30/60
Resistant Influenza
Infection Case Report Form.
Epidemiologist..................... Attachment U--National 550 52 15/60
Respiratory & Enteric
Virus Surveillance System
(NREVSS) (55.83A, B, D)
(electronic).
Epidemiologist..................... Attachment V--National 20 12 15/60
Enterovirus Surveillance
Report: (CDC 55.9)
(electronic).
Epidemiologist..................... Attachment W--National 13 4 15/60
Adenovirus Type Reporting
System (NATRS).
Epidemiologist..................... Attachment X--Middle East 57 3 25/60
Respiratory Syndrome
(MERS) Patient Under
Investigation (PUI) Short
Form.
Epidemiologist..................... Attachment Y--Viral 20 5 5/60
Gastroenteritis Outbreak
Submission Form.
Epidemiologist..................... Attachment AA--Influenza 57 52 5/60
Virus (Electronic, Year
Round), PHLIP_HL7
messaging Data Elements.
Epidemiologist..................... Attachment BB--Influenza 3 52 5/60
virus (electronic, year
round) (PHIN-MS).
Epidemiologist..................... Attachment CC--Suspect 10 5 30/60
Respiratory Virus Patient
Form.
Epidemiologist..................... Attachment EE, Aggregate 52 52 10/60
counts of persons exposed
to Highly Pathogenic Avian
Influenza (HPAI).
Epidemiologist..................... Attachment FF, Pediatric 52 4 15/60
Hepatitis of Unknown
Etiology Medical Record
Abstraction Short Form.
Epidemiologist..................... Attachment GG, Pediatric 52 2 45/60
Hepatitis of Unknown
Etiology Medical Record
Abstraction Form (CRF).
Epidemiologist..................... Attachment HH, Arthropod 57 52 60/60
(Vector)-Borne Diseases
(Non-Human Data).
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2023-01667 Filed 1-26-23; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on January 27, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.